Gut microbiota–mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability–efficacy paradox
Frontiers in Microbiology · 10.06.2026 · 17
DOI: 10.3389/fmicb.2026.1868003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 10.06.2026. Verfasst von Ziyi Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Growing evidence suggests that many plant-derived polysaccharides exert systemic effects through gut microbiota–mediated mechanisms rather than direct absorption. Gastrodia elata polysaccharides (GEPs) represent a promising but mechanistically complex class of bioactive compounds with potential cardiovascular relevance.
Objective
This review aims to examine the role of gut microbiota in mediating the biological effects of GEPs, with particular focus on resolving the bioavailability–efficacy paradox through host–microbe interactions.
Methods
A narrative synthesis of recent literature was conducted, integrating data on microbiota–polysaccharide interactions, microbial fermentation processes, metabolite production, and downstream host signaling pathways.
Results
Due to limited systemic bioavailability, GEPs undergo extensive fermentation by gut microbiota, generating bioactive metabolites such as short-chain fatty acids and secondary bile acids. These metabolites modulate key host pathways including inflammation, oxidative stress, endothelial function, and lipid metabolism. Emerging evidence highlights the central role of the gut–heart axis in mediating these effects.
Conclusion
The biological activity of GEPs is best understood within a microbiota-centered framework. This perspective provides new insights into polysaccharide pharmacology and supports the development of microbiome-targeted therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Fuchun Campus, Hangzhou, Zhejiang, China.
- The Second Hospital of Jiaxing, Jiaxing, Zhejiang, China.
- Department of Physiology, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
Zitieren
APA
Luo, Z., Zhu, S., Lu, Y., Yili, W., & Xu, J. (2026). Gut microbiota–mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability–efficacy paradox. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1868003
Vancouver
Luo Z, Zhu S, Lu Y, Yili W, Xu J. Gut microbiota–mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability–efficacy paradox. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1868003
BibTeX
@article{Luo2026,
author = {Luo, Ziyi and Zhu, Shunyao and Lu, Yiqing and Yili, Wu and Xu, Jiadong},
title = {Gut microbiota–mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability–efficacy paradox},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1868003}
}
EUVIMED